Success Story: EB1A Approved Without RFE! We Helped a Chinese Postdoc Secure Success with Premium Processing Service
Client’s Testimonial:
"Thank you for all your help during my Case preparation!”
On March 3rd, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoc in the Field of Molecular Biosensing (Approval Notice).
General Field: Molecular Biosensing
Position at the Time of Case Filing: Postdoc
Country of Origin: China
State of Residence at the Time of Filing: Texas
Approval Notice Date: March 3rd, 2026
Processing Time: 18 days (Premium Processing Requested)
Case Summary:
Our firm is pleased to share the successful approval of an I-140 EB-1A (Alien of Extraordinary Ability) petition for the client, a distinguished researcher in molecular biosensing. The client holds a Ph.D. in Nutrition and Food Safety and sought to secure permanent residency through the EB-1A category based on a record of sustained influence in aptamer biosensing and molecular imaging. With Premium Processing requested at the time of filing, the petition was approved, reflecting the strength of the evidentiary record and the clarity of the case presentation.
Accomplishments and Expertise
The client has established a strong reputation in molecular biosensing, with specialized expertise in aptamer biosensing and molecular imaging. The petition highlighted the client’s development of enzyme-free, aptamer-based biosensors designed for rapid and reliable pathogen and toxin detection, positioning this work as impactful because it supports scalable diagnostics that can be applied in real-world settings where speed, robustness, and reliability matter.
In presenting the EB-1A case, we emphasized objective achievements while still analyzing how an adjudicator would interpret them. Rather than treating numbers as automatically sufficient, we framed the record as evidence of independent reliance and sustained peer trust:
- 23 peer-reviewed journal articles (5 first-authored)
- 878 citations to the client’s published work, reflecting sustained uptake by independent researchers
- At least 40 completed peer reviews, demonstrating ongoing trust from journals in the client’s technical judgment
- Competitive research support from major funding sources, including the National Institutes of Health, the Robert A. Welch Foundation, the Alzheimer’s Association, and other national-level science agencies
Letters of Recommendation
To further support the petition, we submitted 4 letters of recommendation from highly regarded experts in the field, including independent perspectives. These letters corroborated the objective record by explaining why the client’s enzyme-free aptamer biosensing contributions are considered field-advancing and why continued work in molecular biosensing benefits the United States.
“Collectively, [Client’s] academic and professional background positions her as an influential expert in biosensing research, particularly in the development of programmable diagnostic platforms.”
EB-1A Approval and Outlook
This EB-1A approval underscores how a carefully organized record can demonstrate extraordinary ability through original contributions, independent reliance reflected in citations, and sustained peer trust reflected in peer-review service and competitive support. The client’s continued work in molecular biosensing and molecular imaging is expected to further strengthen diagnostic innovation and broaden the practical reach of rapid detection technologies in the United States.